These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21898101)

  • 1. Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide.
    Asajima H; Saito N; Ohmura Y; Ohmura K
    Eur J Clin Pharmacol; 2012 Mar; 68(3):331-3. PubMed ID: 21898101
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe respiratory failure and torsades de pointes induced by disopyramide in a patient with myasthenia gravis.
    Hirose K; Yamaguchi H; Oshima Y; Choraku M; Hirono A; Takamori N; Tamura K
    Intern Med; 2008; 47(19):1703-8. PubMed ID: 18827420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Torsade de Pointes during mild hypothermia therapy for a survivor of sudden cardiac arrest due to drug-induced long-QT syndrome.
    Matsuhashi T; Sato T; Aizawa Y; Takatsuki S
    J Cardiovasc Electrophysiol; 2010 Apr; 21(4):462-3. PubMed ID: 19845813
    [No Abstract]   [Full Text] [Related]  

  • 4. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).
    Ritter JM
    Br J Clin Pharmacol; 2012 Mar; 73(3):331-4. PubMed ID: 22329611
    [No Abstract]   [Full Text] [Related]  

  • 7. Ibutilide-induced long QT syndrome and torsade de pointes.
    Gowda RM; Punukollu G; Khan IA; Patlola RR; Tejani FH; Cosme-Thormann BF; Vasavada BC; Sacchi TJ
    Am J Ther; 2002; 9(6):527-9. PubMed ID: 12424513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
    Choudhury L; Grais IM; Passman RS
    Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsade de pointes induced by ajmaline.
    Haverkamp W; Mönnig G; Kirchhof P; Eckardt L; Borggrefe M; Breithardt G
    Z Kardiol; 2001 Aug; 90(8):586-90. PubMed ID: 11565214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding torsade de pointes: a bridge to tailored drug therapy?
    Tan HL; Wilde AA
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):87-8. PubMed ID: 12090899
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced QT prolongation.
    Tzivoni D
    Isr Med Assoc J; 2001 Jun; 3(6):472. PubMed ID: 11433657
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug induced QT prolongation and torsades de pointes.
    Yap YG; Camm AJ
    Heart; 2003 Nov; 89(11):1363-72. PubMed ID: 14594906
    [No Abstract]   [Full Text] [Related]  

  • 13. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone.
    Atar S; Freedberg NA; Antonelli D; Rosenfeld T
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):785-6. PubMed ID: 12698686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

  • 17. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.
    Cubeddu LX
    Am J Ther; 2003; 10(6):452-7. PubMed ID: 14624285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.